Bioscience Research Foundation: Pioneering End-to-End Solutions in the CRO Market
By: Dr. C. Tamilselvan, Founder
In the thriving world of contract research organizations (CROs), Bioscience Research Foundation (BRF) is carving a niche for itself by providing end-to-end solutions that meet the unique regulatory requirements of clients in the pharmaceutical, medical device, agrochemical, and other industries. Founded in 2010 by Dr. C. Tamilselvan, BRF has grown to become one of the leading CROs in India, with a comprehensive portfolio of services and capabilities that enable clients to bring their products to market with confidence.
Changing Regulatory Landscape
The CRO market in Asia is poised for significant growth in the coming years, driven by a changing regulatory landscape that places greater emphasis on alternatives to animal testing, advancements in technology that make it easier to conduct regulatory audits, and increasing focus on Chinese manufacturers on expanding their reach in newly regulated markets. To keep up with the evolving regulatory landscape, CROs are investing in new technologies and methods to minimize animal testing while maintaining scientific accuracy. BRF is at the forefront of this trend, offering expertise in understanding and meeting regulatory demands, and developing alternative testing platforms that are both effective and compliant with regulatory requirements.
The company provides end-to-end solutions to clients, beginning with understanding their specific requirements. They engage in detailed discussions to identify needs, the products clients want to register for, and their target markets. Once they have a clear understanding of client needs, they suggest tailored solutions that keep in mind the client’s requirements and their commitment to quality, timeliness, and cost-effectiveness. They offer a range of reports and studies, which they discuss with clients and recommend based on their agreement. BRF provides both phased and complete study reports, and their reports are accepted worldwide.
Solving Pain Points and Providing High- Quality, Coordinated Services
One of the major pain points faced by clients in the CRO market is the need to shop around for various capabilities. Each country has its own unique testing requirements, and not every lab has all the necessary capabilities. To address this issue, BRF has established all the capabilities required for preclinical testing in one location. Their 150,000 square feet of lab space provides end-to-end services, including radio-isotope testing for metabolism studies, long-term studies, and carcinogenicity testing, among others. By providing coordinated services, BRF helps clients save time and resources while ensuring the highest quality of testing.
BRF’s key differentiating factor is its commitment to always putting the customer’s needs first. Unlike other providers who may specialize in only one or two service areas, BRF has invested in all the capabilities that clients might need, enabling them to provide a comprehensive service tailored to the unique needs of each client. Their fully established toxicology lab, complete with DABT toxicologists and multiple in-house pathologists, is one of the few labs in the country with such capabilities. They also have qualified and registered personnel with vast experience and expertise in all departments, making them well-positioned to meet even the most challenging demands that come their way. BRF’s flagship services include clinical chemistry, toxicology, microbiology, safety pharmacology, and animal breeding sites, all designed to ensure the highest quality of testing.
The Powerhouse of Quality Research
Bioscience Research Foundation has come a long way since 2016 when it received its GLP certification. In just eight years, the company has grown to become a leading force in the scientific community. With over 300 highly qualified scientists, BRF is a one-stop shop for all GLPcertified services across seven areas.
When asked about their team, BRF proudly highlights their 11 scientific departments and six support departments, which are led by Dr. C. Tamilselvan, with over three and a half decades of experience. The team includes registered quality professionals in the quality assurance department, DABT registered toxicologists, and some of the most qualified veterinarians in the industry. Additionally, BRF has highly trained ecotoxicology experts and certified radio safety professionals who are recognized by the Atomic Energy Regulatory Board. With 55 PhDs, the team is known for its international experience and qualifications from top universities in India and abroad.
What sets BRF apart from its competitors is its decision to offer the complete spectrum of GLP-certified services across all seven areas. While initially focused on the agrochemical market, BRF quickly diversified to include pharmacology, drug discovery, radioisotopes, and medical devices. This has led to their current expansion plans, which include a brand-new state-of-the-art lab space spanning 50,000 square feet to meet the increasing demands in the pharmaceutical and medical device testing fields. Moreover, a new facility is set to open in the next few months, which will span over 70,000 square feet and be dedicated solely to drug discovery. This facility will have large animal models and certified surgery suites for medical device testing, and BRF will also be expanding its in-house vivarium.
"By providing coordinated services, BRF helps clients save time & resources while ensuring the highest quality of testing"
Looking back on its journey, BRF highlights its growth since receiving its GLP certification in 2016. The facility was constructed in 2015 and GLP was awarded for 7 areas in 2016. In just eight years, they have expanded to a team of 300 professionals, achieved remarkable growth, and diversified their services and geographic reach. However, BRF remains committed to its core values and mission of providing high-quality services to its clients while driving innovation and progress in the scientific community.
Dr. C. Tamilselvan, Founder
Dr. Tamilselvan is a respected leader in the field of science and research, and his expertise and leadership have been instrumental in the success of BRF. His commitment to excellence and his vision for the future of the company has positioned BRF as a leading CRO company in India and a trusted partner for clients around the world.